Home

Fueling health policy solutions through scholarship and science.

Bolstering Domestic Manufacturing for Critical Pharmaceuticals and Ingredients

Event • 11/17/26

Bolstering Domestic Manufacturing for Critical Pharmaceuticals and Ingredients

Register Today

Focus Area

Cross-Cutting Themes

Newsletter

Stay current on the latest from Duke-Margolis Institute by subscribing to our newsletters.

Duke-Margolis Spotlight

Accountable Care in 2027: Building the Evidence Base and Driving Practical Policy Solutions

 

As accountable care enters its next phase, the focus is shifting from proving the model’s value to determining how it can evolve to address persistent challenges related to affordability, provider incentives, data sharing, specialty care integration, and emerging high-cost therapies. Advances in artificial intelligence, digital health, predictive analytics, and real-world evidence generation offer new opportunities to improve outcomes and accelerate innovation, but questions remain about the policy, payment, and technology infrastructure needed to support long-term success. Join policy leaders and industry experts for a discussion on the future of accountable care and opportunities to scale evidence-based approaches that improve population health and lower costs. This event was part of the West Health Accelerator at Duke-Margolis, a collaborative initiative focused on strengthening Medicare accountable care, improving care for older adults, advancing brain health, and integrating transformative therapies into care.

Giving

Thank you for your interest in making a gift to the Duke-Margolis Institute for Health Policy.